Short term traders exiting this one IMHO. Fundamentals intact, looking forward very much to the coming 6 months & beyond.
I continue to hold on the Rock Solid fundamentals.
Professor Ian Frazer is but one pivotal part of Admedus (apologies to the sole hand that was raised in objection to the adoption of this name).
The herpes 2 drug results are very exciting , and of Cardiocel mind boggling. Following the business model of CSL!
Excited for the future,
Pandelis
annual general meeting review, page-33
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |